Respiratory care devices benefit patients with chronic and acute respiratory disorders. As we age, the respiratory system goes through major anatomical, psychological, and immunological modifications. Respiratory care devices treat lung ailments such as chronic bronchitis, TB, chronic and acute lung conditions, asthma, and others. As people age, their lungs start to function worse, which leads to changes in the respiratory system's physiology, functionality, and immune system. Asthma and other respiratory conditions are becoming more prevalent, driving market growth. The thoracic spine and chest wall deformities, among other anatomical anomalies, obstruct the function of the respiratory system and lead to breathing issues. The rise in chronic obstructive pulmonary disease has substantially impacted the market for respiratory care devices.
As the world's population ages and environmental variables affect respiratory health, there is more of a demand for respiratory care equipment. The medical supplies and apparatus referred to as respiratory care equipment, assist patients in controlling respiratory conditions or providing breathing support when required. To recognize, treat, and keep track of respiratory problems, these devices are used in various healthcare settings, including clinics, hospitals, and home care settings. Some of the important variables projected to raise the demand for efficient respiratory devices for diagnosing and monitoring respiratory disorders are the rising prevalence of respiratory illnesses, evolving habits, and an increase in pollution levels.
The requirement for respiratory devices is anticipated to expand over the projected period due to rising technological breakthroughs in respiratory equipment, their convenience of use, and the increasing prevalence of different respiratory disorders worldwide. Increasing government and industry spending on R&D initiatives is also anticipated to fuel market expansion for novel respiratory devices throughout the forecast period. Devices that administer therapeutic aerosols, humidify inspired gas, provide more oxygen, and remove airway secretions are all employed in respiratory treatment. Different supplemental oxygen delivery methods have varying degrees of success in increasing the inspired oxygen concentration.
News:
A technology created by University of Canterbury researchers gives clinicians and patients easier access to respiratory data. A group of PhD students at UC Engineering created software dubbed Breath-to-Breath Observed Biometrics (BOB), which offers real-time breath-to-breath data. It can also evaluate this data and produce a report for doctors to assist in data-driven care. Researchers developed the software after observing how difficult it is for care teams and even patients to access respiratory data. Their creation makes regular condition monitoring and more automated diagnosis possible, which reduces the burden on the entire healthcare system. Physicians can use BOB to modify care if it is no longer the best option.
The respiratory care devices market has been segmented on the basis of therapeutic devices, monitoring devices, diagnostic devices, accessories and consumables, application, and end-users.
Respiratory Care Monitoring Devices Insights
On the basis of monitoring devices, the market has been classified as pulse oximeters, pulse oximeter sensors, pulse oximeter equipment, capnographs, and gas analyzers.
On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.
The European respiratory care devices market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The respiratory care devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The respiratory care devices market in the Middle East and Africa has been segmented into the Middle East and Africa.
Respiratory Care Devices Market Regional Market Summary
In the respiratory care devices market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. According to the Centers for Disease Control and Prevention, in 2015, the number of deaths due to chronic lower respiratory diseases (including asthma) in the US were 155,041 and the number of adults diagnosed with chronic bronchitis was 8.9 million.
The European market is expected to hold the second largest market share. The market growth in this region can be attributed to the rising frequency of diabetic patients, an increasing number of surgeries, and the increasing demand for advanced treatment procedures. According to Eurostat statistics in 2014, there were nearly 382 thousand deaths in the European Union due to respiratory diseases. According to the Global Status Report on Non-Communicable Diseases, 2010 by the World Health Organization (WHO), smoking is predicted to cause about 71% of all lung cancer deaths and 42% of chronic respiratory diseases worldwide.
The Asia-Pacific market is expected to be the fastest growing segment in the near future due to the most dominant causes of respiratory illness and mortality that include tobacco smoking, infections, and air pollution. Factors such as access to optimal treatment facilities, better adoption rate, increase in disposable income, and rising medical tourism help to boost the fastest growing region. The government and NGO's are taking numerous initiatives to spread public awareness and control of the environment regarding the prevention and treatment of respiratory diseases.
The market in the Middle East and Africa is expected to account for the smallest share of the global respiratory care devices market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the global respiratory care devices market are Philips Healthcare (Netherlands), ResMed, Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), and Fisher & Paykel Healthcare Corporation Limited (New Zealand), Becton, Dickinson and Company (US), Chart Industries, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).
Recent Development
Intended Audience
| Report Attribute/Metric | Details |
| Market Size | USD 19.84 Billion |
| CAGR | 8.60% |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Accessories and Consumables, Application and End-users |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Philips Healthcare (Netherlands), ResMed, Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), and Fisher & Paykel Healthcare Corporation Limited (New Zealand), Becton, Dickinson and Company (US), Chart Industries, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland) |
| Key Market Opportunities | Growing demand for point-of-care diagnostic devices in developing regions |
| Key Market Drivers | · Increasing frequency of respiratory diseases· Increasing geriatric population, urbanization, and its adverse effects· Changes in the environment and lifestyle |
Respiratory Care Devices Market Highlights:
Frequently Asked Questions (FAQ) :
The Respiratory care devices market is expected to growth at 8.60% CAGR during the forecast period (2022–2030).
The major key players of global respiratory care devices market are Philips Healthcare (Netherlands), ResMed, Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), and Fisher & Paykel Healthcare Corporation Limited (New Zealand), Becton, Dickinson and Company (US), Chart Industries, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).
The lack of awareness about respiratory problems, intense competition, and the cost associated with the device and the respiratory surgery restraints of Respiratory Care Devices Market.
Increasing frequency of respiratory diseases, increasing geriatric population, urbanization, and its adverse effects, and changes in the environment and lifestyle boosts the growth of the Respiratory Care Devices Market.
By 2030, the Medical Device Cleaning Market value can exceed USD 19.84 Billion .
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
